Open archive
Clear filters
Showing 1-6 of 6 published briefings.
Company archive
New Zealand King Salmon Investments (NZK) briefings
Read that company's published results in release order, newest first.
New Zealand King Salmon Investments (NZK)HY26Released 26 May 2026
Profit swing to NZ$13.8m masks operating cash flow halving to NZ$7.3m
Pre-lease FCF turned negative at NZ$5.0m as capex rose and debtors built, even with biological performance lifting EBITDA to NZ$24.0m.
Published 26 May 2026
Read briefingNew Zealand King Salmon Investments (NZK)HY26Released 25 September 2025
NPAT swung to a $20.8m loss on a $31.2m biological asset write-down
Operating cash flow rose 21.2% to $19.6m, but volumes fell 17% and FY26 pro-forma EBITDA guidance of just $1-7m points to genuine operating pressure.
Published 23 April 2026
Read briefingNew Zealand King Salmon Investments (NZK)FY25Released 27 March 2025
Revenue up 12.8% but NPAT fell 53% on biological-asset fair value swing
Headline NPAT fell on a $7.7m fair-value loss on biological assets versus a $15.8m prior gain, while operating cash flow nearly tripled to $38.5m.
Published 23 April 2026
Read briefingNew Zealand King Salmon Investments (NZK)HY25Released 24 September 2024
NPAT fell 43% but pro-forma EBITDA rose to $13.5m on biological-asset swing
A $7.7m non-cash biological-asset/inventory swing pulled GAAP earnings down even as volumes, revenue and the company's guided pro-forma measure
Published 23 April 2026
Read briefingNew Zealand King Salmon Investments (NZK)FY24Released 27 March 2024
NZK FY24: $24.5m pro-forma EBITDA hit, but $1.4m H2 cash exposes quality gap
Reported NPAT of $28.5m is flattered by a $15.8m fair value uplift and cash conversion ran at just 28.1% as working capital absorbed $12.3m.
Published 22 April 2026
Read briefingNew Zealand King Salmon Investments (NZK)HY24Released 21 September 2023
NZK swung to $10.6m profit and lifted EBITDA guidance to $23.5-27.5m
Recovery from the FY23 mortality event delivered a $36.4m EBITDA swing, but reported EBITDA of $18.5m sits well above pro-forma EBITDA of $10.7m.
Published 22 April 2026
Read briefingGet reporting-season briefings
Get full NZX result briefings by email as new coverage is published.